Neuropsych Social Emotional & Behavioral Outcomes in Youth w/Cancer

Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Boettger, Sadie; El-Shami, Jessica; Francois, Laetitia Claire; Spinelli, Jennifer

  • IRB No: ALTE07C1

    Protocol Abbrev: ALTE07C1

    Principal Investigator: Vincent F. Giusti, MD

    Sub Investigators: AguilarBonilla, Ana MD; Eslin, Don MD; Martin, Rebecca, ARNP; Pope, Michele ARNP; Smith, Amy MD; Story, Allison ARNP; Sullivan Darden, Kelly ARNP; Sutphin, Robert MD; Wieber, Laura ARNP; Levy, Alejandro MD

    Age Group: Pediatric

    Secondary Protocol No: ALTE07C1

    Treatment: Procedure: psychosocial assessment and care Procedure: cognitive assessment Other: quality-of-life assessment Other: questionnaire administration

    Applicable Disease Sites: All Oncology Sites

    Therapies Involved: Non-Treatment ID: NCT00772200

  • Objective

    This research trial studies neuropsychological (learning, remembering or thinking) and behavioral testing in younger patients with cancer.

  • Key Eligibility


    Ages Eligible for Study: 1 Month to 21 Years
    Genders Eligible for Study: Both
    Accepts Healthy Volunteers: No
    Sampling Method: Non-Probability Sample

    Study Population

    Patients on COG Phase III clinical trials.


    Inclusion Criteria:
    •  The patient must be currently be enrolled or plan to be enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning
    •  The patient must have receptive and expressive English language skills